Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects

Humoral Immunity in Immunosuppressed IBD Patients after the Third SARS-CoV-2 Vaccination: A Comparison with Healthy Control Subjects

Introduction: The COVID-19 pandemic is a result of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Vaccination against COVID-19 is crucial for preventing severe illness and controlling the pandemic. This study aimed to examine how immunosuppressed patients with inflammatory bowel disea...

Full description

Bibliographic Details
Main Authors: Richard Vollenberg, Eva Ulla Lorentzen, Joachim Kühn, Tobias Max Nowacki, Jörn Arne Meier, Jonel Trebicka, Phil-Robin Tepasse
Format: Article
Language:English
Published: MDPI AG 2023-08-01
Series:Vaccines
Subjects:
SARS-CoV-2
COVID-19
vaccination
IBD patients
seroconversion
humoral immune response
Online Access:https://www.mdpi.com/2076-393X/11/9/1411

Internet

https://www.mdpi.com/2076-393X/11/9/1411

Similar Items